Comments
Glenmark Pharma slumped as Q4 profit misses estimates.
Shares of Glenmark Pharmaceuticals fell as much as 16.3 per cent in early trade.
The company has posted a consolidated Q4 profit of Rs 184 crore ($28.62 million), missing analysts' estimates of Rs 593 crore, as sales across Europe and Latin America fell.
The stock hit its lowest since June 24, 2016.
The shares posted biggest percentage intraday fall since August 19, 2009.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.